Inceptua improves access to medicine for serious gram-negative bacterial infections in LATAM 16-May-2024 By Liza Laws A study in the American Chemical Society says the demand for new antibiotics is critical.
European Commission offers hope for misunderstood intellectual disability and autism condition, FXS 12-Apr-2024 By Liza Laws The European Commission has granted Orphan Medicinal Product designation for zatolmilast an investigational treatment for Fragile X syndrome (FXS), a leading cause of inherited intellectual disability and autism.